BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 11200789)

  • 1. Rational migraine management: optimising treatment with the triptans.
    Millson DS
    Funct Neurol; 2000; 15 Suppl 3():182-91. PubMed ID: 11200789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of use of triptans and reasons for switching them in a tertiary care migraine population.
    Sheftell FD; Feleppa M; Tepper SJ; Volcy M; Rapoport AM; Bigal ME
    Headache; 2004; 44(7):661-8. PubMed ID: 15209687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
    Chen LC; Ashcroft DM
    Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migraine pharmacotherapy with oral triptans: a rational approach to clinical management.
    Millson DS; Tepper SJ; Rapoport AM
    Expert Opin Pharmacother; 2000 Mar; 1(3):391-404. PubMed ID: 11249525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient satisfaction with rizatriptan versus other triptans: direct head-to-head comparisons.
    Gerth WC; McCarroll KA; Santanello NC; Vandormael K; Zhang Q; Mannix LK
    Int J Clin Pract; 2001 Oct; 55(8):552-6. PubMed ID: 11695077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.
    Tfelt-Hansen P; De Vries P; Saxena PR
    Drugs; 2000 Dec; 60(6):1259-87. PubMed ID: 11152011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rizatriptan: an update of its use in the management of migraine.
    Wellington K; Plosker GL
    Drugs; 2002; 62(10):1539-74. PubMed ID: 12093318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spotlight on rizatriptan in migraine.
    Wellington K; Jarvis B
    CNS Drugs; 2002; 16(10):715-20. PubMed ID: 12269863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migraine: diagnosis, management, and new treatment options.
    Gallagher RM; Cutrer FM
    Am J Manag Care; 2002 Feb; 8(3 Suppl):S58-73. PubMed ID: 11859906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis.
    Thorlund K; Mills EJ; Wu P; Ramos E; Chatterjee A; Druyts E; Goadsby PJ
    Cephalalgia; 2014 Apr; 34(4):258-67. PubMed ID: 24108308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral therapy for migraine: comparisons between rizatriptan and sumatriptan. A review of four randomized, double-blind clinical trials.
    Tfelt-Hansen P; Ryan RE
    Neurology; 2000; 55(9 Suppl 2):S19-24. PubMed ID: 11089515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.
    Ferrari MD; Goadsby PJ; Roon KI; Lipton RB
    Cephalalgia; 2002 Oct; 22(8):633-58. PubMed ID: 12383060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptans and CNS side-effects: pharmacokinetic and metabolic mechanisms.
    Dodick DW; Martin V
    Cephalalgia; 2004 Jun; 24(6):417-24. PubMed ID: 15154851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infrequent or non-response to oral sumatriptan does not predict response to other triptans--review of four trials.
    Dahlöf CG
    Cephalalgia; 2006 Feb; 26(2):98-106. PubMed ID: 16426262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of rizatriptan 10 mg compared with sumatriptan 100 mg: an evidence-based analysis.
    Göbel H
    Expert Rev Neurother; 2010 Apr; 10(4):499-506. PubMed ID: 20367203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic analysis of triptan therapy for acute migraine: a Medicaid perspective.
    Mullins CD; Subedi PR; Healey PJ; Sanchez RJ
    Pharmacotherapy; 2007 Aug; 27(8):1092-101. PubMed ID: 17655509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic pharmacotherapy of migraine.
    Lobo BL; Cooke SC; Landy SH
    Clin Ther; 1999 Jul; 21(7):1118-30. PubMed ID: 10463512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triptan nonresponder studies: implications for clinical practice.
    Dodick DW
    Headache; 2005 Feb; 45(2):156-62. PubMed ID: 15705122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis.
    Lipton RB; Pascual J; Goadsby PJ; Massiou H; McCarroll KA; Vandormael K; Jiang K; Lines CR
    Headache; 2001 Sep; 41(8):754-63. PubMed ID: 11576198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.
    Ferrari MD; Roon KI; Lipton RB; Goadsby PJ
    Lancet; 2001 Nov; 358(9294):1668-75. PubMed ID: 11728541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.